BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 34300274)

  • 1. Chemotherapy for Biliary Tract Cancer in 2021.
    Sasaki T; Takeda T; Okamoto T; Ozaka M; Sasahira N
    J Clin Med; 2021 Jul; 10(14):. PubMed ID: 34300274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gemcitabine-based chemotherapy for advanced biliary tract carcinomas.
    Abdel-Rahman O; Elsayed Z; Elhalawani H
    Cochrane Database Syst Rev; 2018 Apr; 4(4):CD011746. PubMed ID: 29624208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Practical Guide for the Systemic Treatment of Biliary Tract Cancer in Canada.
    Ramjeesingh R; Chaudhury P; Tam VC; Roberge D; Lim HJ; Knox JJ; Asselah J; Doucette S; Chhiber N; Goodwin R
    Curr Oncol; 2023 Jul; 30(8):7132-7150. PubMed ID: 37622998
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacotherapeutic options for biliary tract cancer: current standard of care and new perspectives.
    Filippi R; Lombardi P; Quarà V; Fenocchio E; Aimar G; Milanesio M; Leone F; Aglietta M
    Expert Opin Pharmacother; 2019 Dec; 20(17):2121-2137. PubMed ID: 31550186
    [No Abstract]   [Full Text] [Related]  

  • 5. [Biliary tract cancer: on the way to a personalized therapy].
    Sinn M; Wege H; Stein A
    Dtsch Med Wochenschr; 2020 Apr; 145(7):442-446. PubMed ID: 32236923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Current progress in perioperative chemotherapy for biliary tract cancer.
    Ioka T; Shindo Y; Ueno M; Nagano H
    Ann Gastroenterol Surg; 2023 Jul; 7(4):565-571. PubMed ID: 37416744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The path to personalized treatment in advanced and metastatic biliary tract cancers: a review of new targeted therapies and immunotherapy.
    Demols A; Bucalau AM; Mans L
    Curr Opin Oncol; 2022 Jul; 34(4):403-411. PubMed ID: 35837710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postoperative adjuvant chemotherapy for resectable cholangiocarcinoma.
    Luvira V; Satitkarnmanee E; Pugkhem A; Kietpeerakool C; Lumbiganon P; Pattanittum P
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD012814. PubMed ID: 34515993
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rational development of combination therapies for biliary tract cancers.
    Harding JJ; Khalil DN; Fabris L; Abou-Alfa GK
    J Hepatol; 2023 Jan; 78(1):217-228. PubMed ID: 36150578
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systemic treatment of advanced or recurrent biliary tract cancer.
    Zhang W; Zhou H; Wang Y; Zhang Z; Cao G; Song T; Zhang T; Li Q
    Biosci Trends; 2020 Nov; 14(5):328-341. PubMed ID: 32830166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chemotherapy for cholangiocarcinoma: An update.
    Ramírez-Merino N; Aix SP; Cortés-Funes H
    World J Gastrointest Oncol; 2013 Jul; 5(7):171-6. PubMed ID: 23919111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of chemotherapy in treatments for biliary tract cancer.
    Furuse J; Kasuga A; Takasu A; Kitamura H; Nagashima F
    J Hepatobiliary Pancreat Sci; 2012 Jul; 19(4):337-41. PubMed ID: 22456744
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Possible Next Line of Systemic Therapies for Gemcitabine-Resistant Biliary Tract Cancers: A Perspective from Clinical Trials.
    Chiang NJ; Chen LT; Shan YS; Yeh CN; Chen MH
    Biomolecules; 2021 Jan; 11(1):. PubMed ID: 33451059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Medical treatment for cholangiocarcinoma.
    Adeva J; Sangro B; Salati M; Edeline J; La Casta A; Bittoni A; Berardi R; Bruix J; Valle JW
    Liver Int; 2019 May; 39 Suppl 1():123-142. PubMed ID: 30892822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Targeted therapy for biliary tract cancer.
    Furuse J; Okusaka T
    Cancers (Basel); 2011 May; 3(2):2243-54. PubMed ID: 24212807
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant and neoadjuvant therapy for biliary tract cancer: a review of clinical trials.
    Nara S; Esaki M; Ban D; Takamoto T; Shimada K; Ioka T; Okusaka T; Ishii H; Furuse J
    Jpn J Clin Oncol; 2020 Dec; 50(12):1353-1363. PubMed ID: 33037430
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advances in the treatment of biliary tract cancers.
    Uson Junior PLS; Bogenberger J; Borad MJ
    Curr Opin Gastroenterol; 2020 Mar; 36(2):85-89. PubMed ID: 31972599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Improvement of prognosis for unresectable biliary tract cancer.
    Sasaki T; Isayama H; Nakai Y; Takahara N; Sasahira N; Kogure H; Mizuno S; Yagioka H; Ito Y; Yamamoto N; Hirano K; Toda N; Tada M; Omata M; Koike K
    World J Gastroenterol; 2013 Jan; 19(1):72-7. PubMed ID: 23326165
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cholangiocellular Carcinoma.
    Vogel A; Saborowski A
    Digestion; 2017; 95(3):181-185. PubMed ID: 28288474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Chemotherapy for Biliary Tract Cancer].
    Woo SM
    Korean J Gastroenterol; 2017 Mar; 69(3):172-176. PubMed ID: 28329919
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.